comparemela.com

Latest Breaking News On - Therapeutic area strategy - Page 1 : comparemela.com

J&J: EU marketing authorization application for Rybrevant -December 22, 2023 at 09:01 am EST

Johnson & Johnson announces that it has submitted a marketing authorization application to the European Medicines Agency seeking approval of lazertinib + Rybrevant for the first-line treatment of.

Catherine taylorEuropean medicines agencyVice president medical affairsTherapeutic area strategy

Topline Results from Two-Year Primary Efficacy Endpoint in Pivotal Phase 3 DUPLEX Study of Sparsentan in Focal Segmental Glomerulosclerosis

/PRNewswire/ CSL Vifor today announced topline primary efficacy results from the pivotal Phase 3 DUPLEX Study of sparsentan, a Dual Endothelin Angiotensin.

Steve pascoeVifor internationalFresenius medical careDual endothelin angiotensin receptor antagonistSenior vice presidentTherapeutic area strategyEfficacy endpointsTwo year exploratory endpointsTravere therapeuticsVifor fresenius medical care renal pharmaVifor international ag csl

Vifor International AG (CSL Vifor): Topline Results from Two-Year Primary Efficacy Endpoint in Pivotal Phase 3 DUPLEX Study of Sparsentan in Focal Segmental Glomerulosclerosis

The DUPLEX Study did not achieve the primary efficacy eGFR slope endpoint over 108 weeks of treatment Secondary and topline exploratory endpoints trended favorably for sparsentan Treatment

Steve pascoeFresenius medical careDual endothelin angiotensin receptor antagonistSenior vice presidentTherapeutic area strategyEfficacy endpointsTwo year exploratory endpointsTravere therapeuticsVifor fresenius medical care renal pharma

Amy Mahery, Author at MedCity News

Amy Mahery, Author at MedCity News
medcitynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medcitynews.com Daily Mail and Mail on Sunday newspapers.

Amy maheryExecution leadership teamLeadership teamInternational leadership teamTrinity collegeDiversity councilGlobal business franchiseTherapeutic area strategyChief marketing officer leadership team

Europe approves Ponvory (ponesimod) for multiple sclerosis

Europe approves Ponvory (ponesimod) for multiple sclerosis
europeanpharmaceuticalreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from europeanpharmaceuticalreview.com Daily Mail and Mail on Sunday newspapers.

United kingdomGavin giovannoniCatherine taylorJanssen ponvoryEuropean unionEuropean medicines agencyEuropean commissionDrug administrationCommittee for medicinal products human useProfessor gavin giovannoniQueen mary universityVice presidentMedical affairsTherapeutic area strategyMiddle eastJohnson middle east

vimarsana © 2020. All Rights Reserved.